Therapy Areas: Oncology
28 March 2024 - Kintara Therapeutics, Inc. (Nasdaq: KTRA), a California-based biopharmaceutical company, announced on Wednesday that it has expanded the inclusion criteria in the open label 15-patient...
27 March 2024 - Oncology company Novocure (NASDAQ: NVCR) announced on Wednesday the success of its phase 3 METIS clinical trial, revealing a significant improvement in time to intracranial progression...
27 March 2024 - GE HealthCare (Nasdaq: GEHC), a medical technology, pharmaceutical diagnostics and digital solutions company , announced on Wednesday that it has launched its Prostate Volume Assist (P...
27 March 2024 - Bridge Biotherapeutics (KQ288330), a South Korea-based clinical-stage biotech company, announced on Tuesday that it has entered a research collaboration with Dr. Raul Torres's Lab...
27 March 2024 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Tuesday that it has successfully dosed its first participant with IBI310 (anti-CTLA-4 mono...
26 March 2024 - Personalis Inc (Nasdaq: PSNL), a provider of advanced genomics for precision oncology, on Tuesday announced validation of its NeXT Personal test, an ultra-sensitive circulating tumour ...